Fluorotechnics, which produces and sells high value consumables in the life science tools market, has lodged a prospectus for an initial public offering to raise up to USD12m (GBP6.74m).
The Sydney-based company has developed valuable IP based on proprietary research conducted over the past decade.
Fluorotechnics has specialised manufacturing facilities at North Ryde in Sydney and near Stuttgart in Germany.
The company was spun-out of Macquarie University and the university remains a shareholder.
Fluorotechnics' offer of USD1.00 per share is due to open on 10 September and close on 10 October.
When listed on the ASX, Fluorotechnics will have 26-28 million shares on issue with a market capitalisation of USD26-28m.
The minimum subscription is six million ordinary shares at USD1.00 per share.
The prospectus was lodged with ASIC on 29 August 2008.
